Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,857
archived clinical trials in
Hot Flash

A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
953
mi
from 98109
Valley Village, CA
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
953
mi
from 98109
Valley Village, CA
Click here to add this to my saved trials
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2178
mi
from 98109
Atlanta, GA
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2178
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
399
mi
from 98109
Meridian, ID
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
399
mi
from 98109
Meridian, ID
Click here to add this to my saved trials
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2325
mi
from 98109
Elkridge, MD
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2325
mi
from 98109
Elkridge, MD
Click here to add this to my saved trials
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2150
mi
from 98109
Kingsport, TN
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2150
mi
from 98109
Kingsport, TN
Click here to add this to my saved trials
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1890
mi
from 98109
Houston, TX
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1890
mi
from 98109
Houston, TX
Click here to add this to my saved trials
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
711
mi
from 98109
Riverton, UT
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
711
mi
from 98109
Riverton, UT
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1116
mi
from 98109
Phoenix, AZ
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1116
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2512
mi
from 98109
Clearwater, FL
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2512
mi
from 98109
Clearwater, FL
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2679
mi
from 98109
Jupiter, FL
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2679
mi
from 98109
Jupiter, FL
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1503
mi
from 98109
Kansas City, MO
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1503
mi
from 98109
Kansas City, MO
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1788
mi
from 98109
Schertz, TX
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1788
mi
from 98109
Schertz, TX
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2079
mi
from 98109
Birmingham, AL
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2079
mi
from 98109
Birmingham, AL
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
973
mi
from 98109
Norwalk, CA
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
973
mi
from 98109
Norwalk, CA
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1020
mi
from 98109
Denver, CO
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1020
mi
from 98109
Denver, CO
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2725
mi
from 98109
Hialeah, FL
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2725
mi
from 98109
Hialeah, FL
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2730
mi
from 98109
Miami, FL
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2730
mi
from 98109
Miami, FL
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2651
mi
from 98109
Port Saint Lucie, FL
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2651
mi
from 98109
Port Saint Lucie, FL
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2554
mi
from 98109
Sarasota, FL
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2554
mi
from 98109
Sarasota, FL
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
573
mi
from 98109
Idaho Falls, ID
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
573
mi
from 98109
Idaho Falls, ID
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
872
mi
from 98109
Las Vegas, NV
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
872
mi
from 98109
Las Vegas, NV
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2382
mi
from 98109
LawrenceVille, NJ
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2382
mi
from 98109
LawrenceVille, NJ
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2373
mi
from 98109
Philadelphia, PA
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2373
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1897
mi
from 98109
Jackson, TN
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1897
mi
from 98109
Jackson, TN
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
678
mi
from 98109
Ogden, UT
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
678
mi
from 98109
Ogden, UT
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
701
mi
from 98109
Salt Lake City, UT
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
701
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2449
mi
from 98109
Jacksonville, FL
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2449
mi
from 98109
Jacksonville, FL
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2492
mi
from 98109
Ponte Vedra, FL
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2492
mi
from 98109
Ponte Vedra, FL
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2692
mi
from 98109
West Palm Beach, FL
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2692
mi
from 98109
West Palm Beach, FL
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1435
mi
from 98109
Wichita, KA
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1435
mi
from 98109
Wichita, KA
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2168
mi
from 98109
Bristol, TN
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2168
mi
from 98109
Bristol, TN
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1864
mi
from 98109
Memphis, TN
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1864
mi
from 98109
Memphis, TN
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1660
mi
from 98109
Fort Worth, TX
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1660
mi
from 98109
Fort Worth, TX
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2244
mi
from 98109
Dothan, AL
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2244
mi
from 98109
Dothan, AL
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2172
mi
from 98109
Sandy Springs, GA
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2172
mi
from 98109
Sandy Springs, GA
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2004
mi
from 98109
Columbus, OH
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2004
mi
from 98109
Columbus, OH
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
714
mi
from 98109
Draper, UT
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
714
mi
from 98109
Draper, UT
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2477
mi
from 98109
Crystal River, FL
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2477
mi
from 98109
Crystal River, FL
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2490
mi
from 98109
Morehead City, NC
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2490
mi
from 98109
Morehead City, NC
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2429
mi
from 98109
Norfolk, VA
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2429
mi
from 98109
Norfolk, VA
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2468
mi
from 98109
New London, CT
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2468
mi
from 98109
New London, CT
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2091
mi
from 98109
Metairie, LA
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2091
mi
from 98109
Metairie, LA
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2328
mi
from 98109
Baltimore, MD
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2328
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1819
mi
from 98109
Kalamazoo, MI
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1819
mi
from 98109
Kalamazoo, MI
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1860
mi
from 98109
Saginaw, MI
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1860
mi
from 98109
Saginaw, MI
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1065
mi
from 98109
San Diego, CA
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1065
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2544
mi
from 98109
Orlando, FL
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2544
mi
from 98109
Orlando, FL
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2686
mi
from 98109
Wellington, FL
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2686
mi
from 98109
Wellington, FL
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2100
mi
from 98109
Marrero, LA
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2100
mi
from 98109
Marrero, LA
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2275
mi
from 98109
Winston-Salem, NC
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2275
mi
from 98109
Winston-Salem, NC
Click here to add this to my saved trials